cilostazol and caffeine

cilostazol has been researched along with caffeine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Itoh, T; Kanmura, Y; Shiraishi, Y	1
Hashimoto, A; Hashitani, H; Kito, Y; Mori, T; Nakamura, E; Suzuki, H	1
Achilleus, D; Bowles, EA; Ellsworth, ML; Sprague, RS	1
Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK	1

Reviews

2 review(s) available for cilostazol and caffeine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle. Acta physiologica (Oxford, England), 2011, Volume: 202, Issue:3 Topics: Adenosine Triphosphate; Animals; Caffeine; Cilostazol; Diabetes Mellitus, Type 2; Erythrocytes; Humans; Intercellular Signaling Peptides and Proteins; Microvessels; Muscle, Skeletal; Oxygen; Peptides; Regional Blood Flow; Tetrazoles; Vasodilator Agents	2011

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle.

Acta physiologica (Oxford, England), 2011, Volume: 202, Issue:3

Topics: Adenosine Triphosphate; Animals; Caffeine; Cilostazol; Diabetes Mellitus, Type 2; Erythrocytes; Humans; Intercellular Signaling Peptides and Proteins; Microvessels; Muscle, Skeletal; Oxygen; Peptides; Regional Blood Flow; Tetrazoles; Vasodilator Agents

2011

Other Studies

6 other study(ies) available for cilostazol and caffeine

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit. British journal of pharmacology, 1998, Volume: 123, Issue:5 Topics: Animals; Caffeine; Calcium; Cerebral Arteries; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Rabbits; Ryanodine; Tetrazoles; Thionucleotides	1998
Inhibitory actions of cilostazol on electrical responses of smooth muscle isolated from the guinea-pig stomach antrum. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2004, Volume: 40, Issue:3 Topics: Animals; Caffeine; Cilostazol; Colforsin; Cyclic AMP; Electric Stimulation; Electrophysiology; Evoked Potentials; Guinea Pigs; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth; Phosphodiesterase Inhibitors; Pyloric Antrum; Tetrazoles	2004
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. European journal of pharmacology, 2022, Apr-15, Volume: 921 Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Caffeine; Cilostazol; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Glycogen Synthase Kinase 3 beta; Rats	2022